Spectral AI (NASDAQ: MDAI) ("Spectral AI" or the "Company"), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from ...
DALLAS - Spectral AI, Inc. (NASDAQ:MDAI), a Dallas-based company specializing in medical diagnostics with its AI-driven DeepView® System, has announced its expected financial outcomes for the year ...
Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients ...
Emergen Research Logo. The diabetic foot ulcer treatment market is expected to grow from an estimated USD 5.36 Billion in 2024 to USD 9.21 Billion in 2033, ...
RION, a clinical-stage regenerative medicine company at the forefront of exosome-based therapeutics, announced today that it has completed patient enrollment in its Phase 2 clinical trial for Purified ...
Hyperbaric Oxygen Therapy HBOT has been a topic of growing interest among healthcare professionals athletes and individuals seeking innovative ways to enhance recovery By placing patients in a pressur ...